hVIVO plc (LON:HVO) Plans Dividend of GBX 0.20

hVIVO plc (LON:HVO) declared a dividend on Tuesday, April 9th, Upcoming.Co.Uk reports. Stockholders of record on Thursday, April 18th will be given a dividend of GBX 0.20 ($0.00) per share on Monday, May 20th. This represents a dividend yield of 0.68%. The ex-dividend date is Thursday, April 18th. The official announcement can be accessed at this link.

hVIVO Stock Performance

LON:HVO opened at GBX 27.62 ($0.34) on Wednesday. hVIVO has a twelve month low of GBX 14 ($0.17) and a twelve month high of GBX 32 ($0.40). The company has a current ratio of 1.46, a quick ratio of 1.16 and a debt-to-equity ratio of 9.83. The company has a 50-day moving average of GBX 28.04 and a 200-day moving average of GBX 24.20. The firm has a market cap of £187.89 million, a price-to-earnings ratio of -1.00 and a beta of 0.99.

hVIVO Company Profile

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.